References
- Multigam® [package leaflet]. Brussels: BIOTEST PHARMA GmbH; 2008.
- Goebel A, Netal S, Schedel R, et al. Human pooled immunoglobulin in the treatment of chronic pain syndromes. Pain Med. 2002 Jun;3(2):119–127.
- Chaigne B, Mouthon L. Mechanisms of action of intravenous immunoglobulin. Transfus Apher Sci. 2017 Feb;56(1):45–49.
- Inami.fgov.be. (2017). Immunoglobulinen: vergoedingsvoorwaarden op 1 april 2017 - RIZIV. [online] [cited 18 Jul. 2019]. Available from: https://www.inami.fgov.be/nl/themas/kost-terugbetaling/door-ziekenfonds/geneesmiddel-gezondheidsproduct/terugbetalen/specialiteiten/wijzigingen/Paginas/immunoglobulinen.aspx .
- Wasserman RL, Melamed IR, Stein MR, et al. GMX07 study group. Evaluation of the safety, tolerability, and pharmacokinetics of Gammaplex(®) 10% Versus Gammaplex(®) 5% in subjects with primary immunodeficiency. J Clin Immunol. 2017 Apr;37(3):301–310.